Table of Content
- Introduction
- Definition of Pediatric Brain Tumor Market
- Scope of the Report
- Methodology
- Executive Summary
- Market Overview
- Market Definition and Segmentation
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Porter's Five Forces Analysis
- PESTEL Analysis
- Pediatric Brain Tumor Market, By Types
- Gliomas
- Astrocytoma
- Malignant Gliomas
- Others
- Mixed Neuronal-Glial Tumors
- Ganglioglioma
- Subependymal Giant Cell Tumor
- Pleomorphic Xanthoastrocytoma
- Others
- Embryonal Tumors
- Primitive Neuroectodermal Tumor (PNET)
- Atypical Teratoid/Rhabdoid Tumor
- Others
- Choroid Plexus Papilloma/Carcinoma
- Tumors Arising From Non-Neuroepithelial Tissue
- Craniopharyngioma
- Pineal Region Tumors
- Other
- Meningeal Tumors
- Others
- Gliomas
- Pediatric Brain Tumor Market, By Diagnosis
- Physical Exam
- Imaging Tests
- Magnetic Resonance Imaging (MRI) Scan
- Magnetic Resonance Angiography (MRA)
- Magnetic Resonance Spectroscopy (MRS)
- Magnetic Resonance Perfusion
- Functional MRI (FMRI)
- Others
- Computed Tomography (CT) Scan
- Positron Emission Tomography (PET) Scan
- Angiogram
- Others
- Magnetic Resonance Imaging (MRI) Scan
- Brain Or Spinal Cord Tumor Biopsy
- Stereotactic Needle Biopsy
- Craniotomy
- Others
- Lumbar Puncture (Spinal Tap)
- Blood And Urine Tests
- Others
- Pediatric Brain Tumor Market, By Treatment
- Surgery
- Surgical Biopsy
- Resection (Removal)
- Shunt Placement/Revision
- Others
- Therapies
- Radiation Therapy
- Chemotherapy
- Carboplatin
- Carmustine (BCNU)
- Cisplatin
- Cyclophosphamide
- Etoposide
- Lomustine (CCNU)
- Methotrexate
- Temozolomide
- Thiotepa
- Vincristine
- Others
- Targeted Therapy
- Others
- Surgery
- Pediatric Brain Tumor Market, By End User
- Hospitals And Clinics
- Medical Research Centers
- Academic Institutes
- Others
- Pediatric Brain Tumor Market, By Geography
- North America
- United States
- Canada
- Europe
- United Kingdom
- Germany
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of Middle East & Africa
- North America
- Competitive Landscape
- Company Profiles
- Abbott. (US)
- Company Overview
- Product Portfolio and Description
- Key Highlights
- Financial Overview
- AbbVie Inc. (US)
- Akorn Inc. (US)
- Agios Inc. (US)
- Baxter (US)
- Bayer AG (US)
- Epizyme Inc. (US)
- Novartis AG (Switzerland)
- Mylan N.V. (US)
- Abbott. (US)
- Conclusion and Future Outlook
- Appendix
- Research Methodology
- About the Pharmanucleus
- Disclaimer